Welsh Carson commits up to $250m to newly-formed cell, gene science investor Kiniciti
Private equity major Welsh, Carson, Anderson & Stowe has agreed to commit up to $250m to a strategic partnership with newly-formed Kiniciti, to invest in non-therapeutic companies supporting cell and gene therapy innovation.
